 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Synthetic Biologics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:SYN! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Synthetic Biologics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Synthetic Biologics, Inc., a clinical-stage company develops therapeutics to treat gastrointestinal diseases in the United States. Its lead product candidates include SYN-004 that has completed Phase II clinical trial designed to degrade commonly used intravenous beta-lactam antibiotics in gastrointestinal tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients. The company is also developing SYN-010 that is in Phase IIb/III clinical trial to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-020, an early-stage oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. In addition, its clinical stage products include SYN-006 and SYN-007 for the prevention of CDI, overgrowth of pathogenic organisms, and AMR; and SYN-005 for the prevention and treatment of pertussis. Synthetic Biologics, Inc. has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. The company is headquartered in Rockville, Maryland.
Volume médio
31.49 million shs
MERCADO CAP
$19.99 million
Bolsa de Valores
NYSEAMERICAN
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
AMEX: SYN
|
Preparações farmacêuticas
|
Médico
|
317,349 shs
|
Below is a quick guide on how to buy AMEX:SYN stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Synthetic Biologics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Synthetic Biologics – Search for “”AMEX:SYN”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Synthetic Biologics stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Synthetic Biologics in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Synthetic Biologics stock.
Wall Street analysts have given Synthetic Biologics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Synthetic Biologics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:SYN stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Synthetic Biologics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Synthetic Biologics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “AMEX:SYN stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some AMEX:SYN stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:SYN is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Synthetic Biologics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Synthetic Biologics is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Synthetic Biologics.
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) released its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.14) earnings per share (EPS) for the quarter.
View Synthetic Biologics’ earnings history.
Synthetic Biologics’ stock was trading at $0.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYN shares have increased by 155.6% and is now trading at $0.92.
Synthetic Biologics’s stock reverse split on the morning of Monday, August 13th 2018. The 1-35 reverse split was announced on Wednesday, August 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 10th 2018. An investor that had 100 shares of Synthetic Biologics stock prior to the reverse split would have 3 shares after the split.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:SYN stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
2 Wall Street analysts have issued 12 month target prices for Synthetic Biologics’ stock. Their forecasts range from $1.25 to $1.50. On average, they expect Synthetic Biologics’ stock price to reach $1.38 in the next twelve months. This suggests a possible upside of 49.5% from the stock’s current price.
View analysts’ price targets for Synthetic Biologics or view top-rated stocks among Wall Street analysts.
Synthetic Biologics saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 1,810,000 shares, an increase of 565.4% from the December 31st total of 272,000 shares. Based on an average trading volume of 11,400,000 shares, the days-to-cover ratio is currently 0.2 days.
View Synthetic Biologics’ Short Interest.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Synthetic Biologics’ management team includes the following people:
Mr. Steven A. Shallcross CPA, CEO, CFO, Treasurer, Corp. Sec. & Director (Age 60, Pay $989.81k)
Vincent I. Perrone, Director of Corp. Communication
Dr. Vince Wacher, Head of Product and Corp. Devel.
Dr. Michael Kaleko, Sr. VP of R&D
Ms. Lara M. Guzman, Sr. Director of Project Operations
Some companies that are related to Synthetic Biologics include Aeterna Zentaris (AEZS), Elite Pharmaceuticals (ELTP), Vaccinex (VCNX), Mereo BioPharma Group (MREO), CannTrust (CNTTF), Catabasis Pharmaceuticals (CATB), CV Sciences (CVSI), Iterum Therapeutics (ITRM), Celsion (CLSN), Acerus Pharmaceuticals (ASPCF), Trevi Therapeutics (TRVI), CNS Pharmaceuticals (CNSP), Regulus Therapeutics (RGLS), Appili Therapeutics (APLIF) and Pulmatrix (PULM).
View all of SYN’s competitors.
Based on aggregate information from Reportlab, some companies that other Synthetic Biologics investors own include Synergy Pharmaceuticals (SGYP), Tonix Pharmaceuticals (TNXP), Agenus (AGEN), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), CorMedix (CRMD), Idera Pharmaceuticals (IDRA), Ampio Pharmaceuticals (AMPE) and Navidea Biopharmaceuticals (NAVB).
Synthetic Biologics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “SYN.”
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
Synthetic Biologics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.63%). Company insiders that own Synthetic Biologics stock include Randal J Kirk and Steven A Shallcross.
View institutional ownership trends for Synthetic Biologics.
SYN stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC.
View insider buying and selling activity for Synthetic Biologics or or view top insider-buying stocks.
Shares of SYN can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of SYN stock can currently be purchased for approximately $0.92.
Synthetic Biologics has a market capitalization of $18.39 million.
Synthetic Biologics employs 11 workers across the globe.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy Synthetic Biologics stock on the internet?
You can easily buy Synthetic Biologics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment to trade in.
Where to buy Synthetic Biologics stock?
You will first want to find a licensed broker that supports AMEX:SYN stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment.
Is AMEX:SYN stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:SYN stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Synthetic Biologics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:SYN is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Synthetic Biologics stock.
How do you trade Synthetic Biologics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Synthetic Biologics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:SYN stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Synthetic Biologics stock?
To sell your AMEX:SYN stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Synthetic Biologics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:SYN stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
